UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome

Journal of pineal research, 2014-01, Vol.56 (1), p.51-61

2014

Volltextzugriff (PDF)

Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome

Journal of pineal research, 2013-04, Vol.54 (3), p.346-358

2013

Volltextzugriff (PDF)

Melatonin: A Molecule for Reducing Breast Cancer Risk

Molecules (Basel, Switzerland), 2018-02, Vol.23 (2), p.336

2018

Volltextzugriff (PDF)

Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders

Current medicinal chemistry, 2017-11, Vol.24 (35), p.3851

2017

Volltextzugriff (PDF)

Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome

Neurochemical research, 2016-11, Vol.41 (11), p.2904-2913

2016

Volltextzugriff (PDF)

Melatonin-estrogen interactions in breast cancer

Journal of pineal research, 2005-05, Vol.38 (4), p.217-222

2005

Volltextzugriff (PDF)

Constitutive photomorphogenesis protein 1 (COP1) and COP9 signalosome, evolutionarily conserved photomorphogenic proteins as possible targets of melatonin

Journal of pineal research, 2016-08, Vol.61 (1), p.41-51

2016

Volltextzugriff (PDF)

Melatonin modulates aromatase activity in MCF-7 human breast cancer cells

Journal of pineal research, 2005-03, Vol.38 (2), p.136-142

2005

Volltextzugriff (PDF)

Melatonin inhibits the growth of DMBA‐induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity

International journal of cancer, 2006-01, Vol.118 (2), p.274-278

2006

Volltextzugriff (PDF)

Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation

Expert opinion on investigational drugs, 2012-06, Vol.21 (6), p.819-831

2012

Volltextzugriff (PDF)

Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats

Cancer letters, 2006-04, Vol.235 (2), p.266-271

2006

Volltextzugriff (PDF)

Clinical Uses of Melatonin in Pediatrics

International Journal of Pediatrics, 2011-01, Vol.2011 (2011), p.263-273

2011

Volltextzugriff (PDF)

Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro?

Journal of pineal research, 2002-03, Vol.32 (2), p.90-96

2002

Volltextzugriff (PDF)

Pre- and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of Down syndrome

Behavioural brain research, 2017-09, Vol.334, p.142-154

2017

Volltextzugriff (PDF)

Estrogen-signaling pathway: A link between breast cancer and melatonin oncostatic actions

Cancer detection and prevention, 2006-01, Vol.30 (2), p.118-128

2006

Volltextzugriff (PDF)

Melatonin enhances the inhibitory effect of aminoglutethimide on aromatase activity in MCF-7 human breast cancer cells

Breast cancer research and treatment, 2005-12, Vol.94 (3), p.249-254

2005

Volltextzugriff (PDF)

Melatonin down-regulates hTERT expression induced by either natural estrogens (17β-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells

Cancer letters, 2008-09, Vol.268 (2), p.272-277

2008

Volltextzugriff (PDF)

Role of melatonin in the epigenetic regulation of breast cancer

Breast cancer research and treatment, 2009-05, Vol.115 (1), p.13-27

2009

Volltextzugriff (PDF)

Breast Cancer Therapy Based on Melatonin

Recent patents on endocrine, metabolic & immune drug discovery, 2012-05, Vol.6 (2), p.108-116

2012

Volltextzugriff (PDF)

Smith-magenis syndrome : A case report of improved sleep after treatment with β1-adrenergic antagonists and melatonin

The Journal of pediatrics, 2006-09, Vol.149 (3), p.409-411

2006

Volltextzugriff (PDF)

Melatonin modulates the cadmium-induced expression of MT-2 and MT-1 metallothioneins in three lines of human tumor cells (MCF-7, MDA-MB-231 and HeLa)

Toxicology letters, 2008-10, Vol.181 (3), p.190-195

2008

Volltextzugriff (PDF)

Recent patents on light based therapies: photodynamic therapy, photothermal therapy and photoimmunotherapy

Recent patents on endocrine, metabolic & immune drug discovery, 2014-01, Vol.8 (1), p.1-8

2014

Volltextzugriff (PDF)

Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of D own syndrome

Journal of pineal research, 2014-01, Vol.56 (1), p.51-61

2014

Volltextzugriff (PDF)

Long‐term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle‐aged T s65 D n mice, a model of D own syndrome

Journal of pineal research, 2013-04, Vol.54 (3), p.346-358

2013

Volltextzugriff (PDF)

Melatonin and Mammary Pathological Growth

Frontiers in neuroendocrinology, 2000-04, Vol.21 (2), p.133-170

2000

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(39)
Buchkapitel
(1)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome

Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome

Melatonin: A Molecule for Reducing Breast Cancer Risk

Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders

Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome

Melatonin-estrogen interactions in breast cancer

Constitutive photomorphogenesis protein 1 (COP1) and COP9 signalosome, evolutionarily conserved photomorphogenic proteins as possible targets of melatonin

Melatonin modulates aromatase activity in MCF-7 human breast cancer cells

Melatonin inhibits the growth of DMBA‐induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity

Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation

Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats

Clinical Uses of Melatonin in Pediatrics

Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro?

Pre- and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of Down syndrome

Estrogen-signaling pathway: A link between breast cancer and melatonin oncostatic actions

Melatonin enhances the inhibitory effect of aminoglutethimide on aromatase activity in MCF-7 human breast cancer cells

Melatonin down-regulates hTERT expression induced by either natural estrogens (17β-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells

Role of melatonin in the epigenetic regulation of breast cancer

Breast Cancer Therapy Based on Melatonin

Smith-magenis syndrome : A case report of improved sleep after treatment with β1-adrenergic antagonists and melatonin

Melatonin modulates the cadmium-induced expression of MT-2 and MT-1 metallothioneins in three lines of human tumor cells (MCF-7, MDA-MB-231 and HeLa)

Recent patents on light based therapies: photodynamic therapy, photothermal therapy and photoimmunotherapy

Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of D own syndrome

Long‐term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle‐aged T s65 D n mice, a model of D own syndrome

Melatonin and Mammary Pathological Growth

Suchergebnisse filtern